TR201000731A2 - Pharmaceutical composition in dry powder form comprising tiotropium and fluticasone. - Google Patents

Pharmaceutical composition in dry powder form comprising tiotropium and fluticasone.

Info

Publication number
TR201000731A2
TR201000731A2 TR2010/00731A TR201000731A TR201000731A2 TR 201000731 A2 TR201000731 A2 TR 201000731A2 TR 2010/00731 A TR2010/00731 A TR 2010/00731A TR 201000731 A TR201000731 A TR 201000731A TR 201000731 A2 TR201000731 A2 TR 201000731A2
Authority
TR
Turkey
Prior art keywords
tiotropium
fluticasone
dry powder
pharmaceutical composition
powder form
Prior art date
Application number
TR2010/00731A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/00731A priority Critical patent/TR201000731A2/en
Priority to EP11706368.5A priority patent/EP2528600B1/en
Priority to PCT/TR2011/000015 priority patent/WO2011093813A1/en
Publication of TR201000731A2 publication Critical patent/TR201000731A2/en
Priority to US13/531,972 priority patent/US8834931B2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, tiotropyum ve flutikazon ve/veya bunların farmasötik olarak kabul edilebilir türevlerinin kombinasyonlarını içeren kura toz formundaki farmasötik kompozisyonlara ve bunları içeren blister formlarına ilişkindir.The present invention relates to pharmaceutical compositions in the form of dry powder containing combinations of tiotropium and fluticasone and / or pharmaceutically acceptable derivatives thereof for use in respiratory disorders and blister forms containing them.

TR2010/00731A 2009-12-25 2010-02-02 Pharmaceutical composition in dry powder form comprising tiotropium and fluticasone. TR201000731A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2010/00731A TR201000731A2 (en) 2010-02-02 2010-02-02 Pharmaceutical composition in dry powder form comprising tiotropium and fluticasone.
EP11706368.5A EP2528600B1 (en) 2010-01-28 2011-01-28 Dry powder pharmaceutical composition comprising tiotropium and fluticasone
PCT/TR2011/000015 WO2011093813A1 (en) 2010-01-28 2011-01-28 Dry powder pharmaceutical composition comprising tiotropium and fluticasone
US13/531,972 US8834931B2 (en) 2009-12-25 2012-06-25 Dry powder formulation containing tiotropium for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/00731A TR201000731A2 (en) 2010-02-02 2010-02-02 Pharmaceutical composition in dry powder form comprising tiotropium and fluticasone.

Publications (1)

Publication Number Publication Date
TR201000731A2 true TR201000731A2 (en) 2011-08-22

Family

ID=44950392

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/00731A TR201000731A2 (en) 2009-12-25 2010-02-02 Pharmaceutical composition in dry powder form comprising tiotropium and fluticasone.

Country Status (1)

Country Link
TR (1) TR201000731A2 (en)

Similar Documents

Publication Publication Date Title
IL268756B (en) Piperazine-2,5-dione derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
CY1120605T1 (en) DRY POWDER PREPARATION INCLUDING A PHOSPHODIESTERATION INHIBITOR
IL227594A (en) Substituted aminobutyric derivatives as neprilysin inhibitors, process for their preparation, pharmaceutical compositions comprising them and use thereof for preparation of medicaments
IL223795A (en) Tetrahydro-pyrido-pyrimidine derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments
TR201000680A2 (en) Pharmaceutical compositions containing tiotropium, formoterol and budesonide
TR201000733A2 (en) Pharmaceutical compositions comprising fluticasone, tiotropium and sodium chromoglycate.
TR201000681A2 (en) Dry powder formulations inhaled.
BR112015027017A2 (en) inhalable pharmaceutical compositions and inhaler devices containing the same
EA201491281A1 (en) COMPOSITION IN THE FORM OF DRY POWDER CONTAINING CORTICOSTEROIDS AND β-ADRENERGIC MEDICINE FOR INTRODUCTION BY INHALATION
IL225105A (en) Heterocyclic compounds, process for their preparation, pharmaceutical compositions comprising them and use thereof for the preparation of medicaments
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
CL2015002702A1 (en) Micronized pharmaceutical compositions.
TR200907913A2 (en) Pharmaceutical composition in dry powder form for inhalation
WO2011093811A3 (en) Pharmaceutical preparations comprising formoterol and fluticasone
TR200907914A2 (en) Pharmaceutical composition in the form of a dry powder containing corticosteroid.
TR201000731A2 (en) Pharmaceutical composition in dry powder form comprising tiotropium and fluticasone.
TR201000624A2 (en) Pharmaceutical composition in dry powder form comprising tiotropium and fluticasone.
TR200907915A2 (en) Pharmaceutical composition in dry powder form.
TR201000730A2 (en) Pharmaceutical composition in dry powder form comprising tiotropium and mometasone.
TR201000732A2 (en) Pharmaceutical composition in dry powder form containing tiotropium and budesonide
TR201000621A2 (en) Pharmaceutical composition in dry powder form containing tiotropium and budesonide
TR201000619A2 (en) Pharmaceutical composition in dry powder form comprising tiotropium and mometasone.
TR201000729A2 (en) Pharmaceutical composition in dry powder form containing tiotropium and ciclesonide
EA201500446A1 (en) PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL